ENTITY
Mezzion Pharma

Mezzion Pharma (140410 KS)

16
Analysis
Health Care • South Korea
Mezzion Pharma Co Ltd develops pharmaceutical products and out-licenses them to foreign countries including Canada, Mexico, Russia, and the United States. The Company's main products are for benign prostatic hyperplasia and erectile dysfunction.
more
bearish•HKEX
•04 Nov 2019 08:45

Stock Short Ideas Within an Index Long Environment

Positioning is quickly shifting to more index net longs and we are on the hunt for stock shorts in Asia given the more bullish Q4 seasonality and...

Share
bearish•Quantitative Analysis
•16 Oct 2019 06:41

Korea - The Shorts Must Be Crazy (On Some Names)!

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 11 October.Current...

Logo
532 Views
Share
•26 Aug 2018 23:31

EM Strategy: Remain Overweight India

In this report we provide a synopsis of EM markets. We also scour the EM universe for attractive and actionable opportunities, highlighting...

Logo
526 Views
Share
•01 Jun 2017 14:39

Summary of KOSPI200 & KOSDAQ150 Upcoming Reshuffle

As I said in my earlier comment, Samsung Biologics Co., Ltd (207940 KS) seems to be benefiting a lot from its inclusion in KOSPI200 index. Perhaps...

Logo
2.3k Views
Share
•07 Jul 2016 00:13

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...

Logo
3.6k Views
Share
x